Live Quote · NASDAQRPTXHealthcare· Biotechnology

Repare Therapeutics Inc.

$2.65 0.00%(+$0.00)
TickerSpark Score
72/100
Solid
85
Valuation
30
Profitability
60
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RPTX research report →

52-Week Range99% of range
Low
$0.89
Current
$2.65
High
$2.66
Company Overviewwww.reparerx.com

About the company

Repare Therapeutics Inc. is a precision oncology biopharmaceutical company in the clinical stage, focused on discovering and developing innovative therapies. Operating across Canada and the United States, the company leverages a synthetic lethality approach to identify new treatments.

CEO
Steve Forte
IPO
2020
Employees
129
HQ
Montreal, QC, CA

Price Chart

+130.43% · this period
$2.65$1.77$0.90Jan 28Jul 30Jan 28
Valuation
Market Cap
$114.24M
P/E
-2.59
P/S
9.62
P/B
0.99
EV/EBITDA
-0.87
Div Yield
0.00%
Profitability
Gross Margin
26.81%
Op Margin
-374.36%
Net Margin
-366.71%
ROE
-37.24%
ROIC
-38.48%
Growth & Income
Revenue
$53.48M · 4.58%
Net Income
$-84,689,000 · 9.71%
EPS
$-2.00 · 10.31%
Op Income
$-93,523,000
FCF YoY
40.78%
Performance & Tape
52W High
$2.66
52W Low
$0.89
50D MA
$2.35
200D MA
$1.75
Beta
0.96
Avg Volume
1.18M

Get TickerSpark's AI analysis on RPTX

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 28, 26BVF PARTNERS L P/ILother548,938
Jan 28, 26SCHAFER CAROLsell37,941
Jan 28, 26SCHAFER CAROLsell8,000
Jan 28, 26RHOADS ANN Dsell4,000
Jan 28, 26Civik Thomassell7,500
Jan 28, 26Forte Stevesell325,800
Jan 28, 26Forte Stevesell85,000
Jan 28, 26Forte Stevesell56,786
Jan 28, 26Forte Stevesell500,000
Jan 28, 26Alves Sandra Isabelle Barrossell26,000
Coverage · RPTX

Our RPTX coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on RPTX yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate RPTX report →
Internal Compare

Similar companies

Peers in the same neighborhood.